Table 2.
The baseline characteristics of subjects among the three groups.
| Group | 1 | 2 | 3 | p value |
|---|---|---|---|---|
| Gender (M/F) | 5/5 | 14/12 | 26/9 | 0.16 |
| Age (year) | 56.5 ± 8.9 | 57.9 ± 4.7 | 53.8 ± 7.3 | 0.06 |
| Duration (month) | 103.1 ± 66.4 | 113.6 ± 62.8 | 107.9 ± 65.1 | 0.89 |
| Numbers of OADs (n) | 0.06 | |||
| 1 | 1 | 8 | 2 | |
| 2 | 8 | 12 | 24 | |
| 3 | 1 | 6 | 9 | |
| OADs | ||||
| Met(-/+) | 4/6 | 7/19 | 4/31 | 0.10 |
| SU (-/+) | 2/8 | 9/17 | 5/30 | 0.17 |
| Weight (kg) | 68.8 ± 10.2 | 65.2 ± 12.6 | 70.9 ± 9.5 | 0.13 |
| BMI (kg/m2) | 25.7 ± 3.1 | 24.6 ± 3.0 | 25.6 ± 2.4 | 0.29 |
| Waist (cm) | 92.2 ± 10.6 | 89.9 ± 9.8 | 93.0 ± 7.6 | 0.41 |
| Hb (g) | 139.4 ± 10.5 | 143.6 ± 10.0 | 144.0 ± 11.3 | 0.48 |
| Cr (mmol/L) | 62.5 ± 13.0 | 59.0 ± 14.7 | 65.0 ± 12.2 | 0.26 |
| ALT (U/L) | 31.1 ± 15.9 | 29.3 ± 14.5 | 35.6 ± 18.3 | 0.34 |
| AST (U/L) | 20.0 ± 6.5 | 20.8 ± 7.2 | 21.3 ± 10.2 | 0.91 |
| TG (mmol/L) | 2.1 ± 1.6 | 2.0 ± 1.4 | 2.0 ± 1.1 | 0.94 |
| TC (mmol/L) | 5.2 ± 1.0 | 5.5 ± 1.2 | 5.2 ± 1.1 | 0.59 |
| HDL (mmol/L) | 1.3 ± 0.3 | 1.5 ± 0.3 | 1.3 ± 0.3 | 0.09 |
| LDL (mmol/L) | 2.8 ± 0.6 | 2.9 ± 0.9 | 2.8 ± 0.9 | 0.98 |
BMI: body mass index; Hb: hemoglobin; Cr: creatinine; ALT: alanine aminotransferase; AST: aspartate aminotransferase; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol; TG: triglyceride; TC: total cholesterol; OADs: oral antidiabetic drugs; Met: metformin; SU: sulfonylurea.